IMM News: Immutep Appoints Dr. Florian Vogl as Chief Medical Officer - 26th Apr 2023, 10:00pm

annb0t

Top 20
Immutep Limited

Media Release

SYDNEY, AUSTRALIA, April 26, 2023 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune diseases, today announces that Florian D. Vogl, M.D., Ph.D., MSc, has been appointed as Chief Medical Officer (CMO) with effect from 1 May 2023.

Dr. Vogl brings to Immutep over a decade of experience in the biopharmaceutical industry with extensive clinical developm...

>>> Read more: Immutep Appoints Dr. Florian Vogl as Chief Medical Officer
 
Top Bottom